Given that the protein levels of ATG5 and ATG12 are not altered in the brains of AD patients12, we sought to examine ATG5 and ATG12 mRNA levels in human induced pluripotent stem cell (iPSC)-derived neural progenitor stem cells isolated from a patient with AD. The gene discussed is ATG5; the disease is Alzheimer disease.